Mounjaro® (tirzepatide) — Eli Lilly

The most advanced dual-mechanism GLP-1 + GIP molecule available. Tirzepatide acts on both receptors simultaneously — greater appetite suppression and metabolic effect than GLP-1 alone. Sourced directly from Eli Lilly, manufactured in the USA and Ireland, through Colombia's tier-one regulated pharmacy network. Not compounded. The original product — in vial format.

Prescription required. Clinical evaluation available.